Struvite Renal Calculi — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for struvite renal calculi. 10 active patents protecting 1 drugs from 1+ originators. First major cliff: 2028. Daily refresh.

1
Approved drugs
10
Active US patents
56/100
Avg vulnerability
—
Annual revenue covered

Originators in Struvite Renal Calculi

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Baxter 10 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating struvite renal calculi. Each bar = one year. Y-axis scaled to peak year (4 patents).

2
28
4
33
3
34
1
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Renacidin
CITRIC ACID
 Baxter 10 56 — 2028-10-10

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11992472 Renacidin method of use 75 2033-03-15
11337989 Renacidin method of use 70 2033-03-15
10568855 Renacidin method of use 62 2033-03-15
11191753 Renacidin method of use 62 2034-06-23
9827231 Renacidin method of use 62 2034-06-26
8481083 Renacidin formulation 60 2028-10-10
8450338 Renacidin formulation 60 2028-10-10
12458634 Renacidin formulation 55 2038-01-27
10624879 Renacidin formulation 42 2034-06-23
11439610 Renacidin composition of matter 12 2033-03-15

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11439610 Renacidin composition of matter 12 2033-03-15
10624879 Renacidin formulation 42 2034-06-23
12458634 Renacidin formulation 55 2038-01-27
8481083 Renacidin formulation 60 2028-10-10
8450338 Renacidin formulation 60 2028-10-10
9827231 Renacidin method of use 62 2034-06-26
11191753 Renacidin method of use 62 2034-06-23
10568855 Renacidin method of use 62 2033-03-15
11337989 Renacidin method of use 70 2033-03-15
11992472 Renacidin method of use 75 2033-03-15

Related